These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2783927)

  • 1. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography.
    Bonte FJ; Devous MD; Reisch JS; Ajmani AK; Weiner MF; Hom J; Tintner R
    Invest Radiol; 1989 Feb; 24(2):99-103. PubMed ID: 2783927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography.
    Bonte FJ; Devous MD; Reisch JS
    Invest Radiol; 1988 Aug; 23(8):564-8. PubMed ID: 3262097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide.
    Dahl A; Russell D; Rootwelt K; Nyberg-Hansen R; Kerty E
    Stroke; 1995 Dec; 26(12):2302-6. PubMed ID: 7491655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of quantification analysis software for measuring regional cerebral blood flow by the modified split-dose method with (123)I-IMP before and after acetazolamide loading].
    Nagaki A; Kobara K; Matsutomo N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 Dec; 59(12):1573-9. PubMed ID: 15001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET.
    Takeuchi R; Yonekura Y; Matsuda H; Konishi J
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):331-41. PubMed ID: 12002707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography.
    Sase S; Yamamoto H; Kawashima E; Tan X; Sawa Y
    Psychogeriatrics; 2018 Jan; 18(1):3-12. PubMed ID: 28745443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-day protocol for cerebral perfusion reserve with acetazolamide.
    Hattori N; Yonekura Y; Tanaka F; Fujita T; Wang J; Ishizu K; Okazawa H; Tamaki N; Konishi J
    J Nucl Med; 1996 Dec; 37(12):2057-61. PubMed ID: 8970534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetazolamide on cerebral artery blood velocity and regional cerebral blood flow in normal subjects.
    Sorteberg W; Lindegaard KF; Rootwelt K; Dahl A; Nyberg-Hansen R; Russell D; Nornes H
    Acta Neurochir (Wien); 1989; 97(3-4):139-45. PubMed ID: 2785746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet's disease.
    Pupi A; Sestini S; De Cristofaro MT; Emmi L; Marchione T; Salvati G; Gobbi FL; Massacesi L; Meldolesi U
    Eur J Nucl Med; 2000 Jun; 27(6):700-6. PubMed ID: 10901457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of time dependency of the acetazolamide effect on cerebral hemodynamics as measured by 99mTc-ECD single-photon emission computed tomography].
    Takaki A; Mizuta Y; Murakami M; Yonehara T; Urata J; Okada K; Takaki R; Hirano T; Fujioka S
    Kaku Igaku; 2001 Jan; 38(1):31-8. PubMed ID: 11257761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.
    Nishizawa S; Iida H; Tsuchida T; Ito H; Konishi J; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):943-50. PubMed ID: 12734690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Masuda K
    Stroke; 1995 Oct; 26(10):1825-9. PubMed ID: 7570733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three brain SPECT region-of-interest templates in elderly people: normative values, hemispheric asymmetries, and a comparison of single- and multihead cameras.
    Lobaugh NJ; Caldwell CB; Black SE; Leibovitch FS; Swartz RH
    J Nucl Med; 2000 Jan; 41(1):45-56. PubMed ID: 10647604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow deficits in mild Alzheimer's disease using high resolution single photon emission computerized tomography.
    Trollor JN; Sachdev PS; Haindl W; Brodaty H; Wen W; Walker BM
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):280-90. PubMed ID: 15896221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
    Murakami M; Yonehara T; Takaki A; Fujioka S; Hirano T; Ushio Y
    J Nucl Med; 2002 May; 43(5):577-83. PubMed ID: 11994517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.